Follow
Jan Albert Kuivenhoven
Jan Albert Kuivenhoven
University Medical Center Groningen
Verified email at umcg.nl
Title
Cited by
Cited by
Year
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
169992017
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of …
BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ...
European heart journal 34 (45), 3478-3490, 2013
29832013
Lipoprotein (a) as a cardiovascular risk factor: current status
BG Nordestgaard, MJ Chapman, K Ray, J Borén, F Andreotti, GF Watts, ...
European heart journal 31 (23), 2844-2853, 2010
21172010
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
MJ Chapman, HN Ginsberg, P Amarenco, F Andreotti, J Borén, ...
European heart journal 32 (11), 1345-1361, 2011
15822011
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on …
M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ...
European heart journal 35 (32), 2146-2157, 2014
10952014
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
A Wiegman, SS Gidding, GF Watts, MJ Chapman, HN Ginsberg, M Cuchel, ...
European heart journal 36 (36), 2425-2437, 2015
8932015
The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis
JA Kuivenhoven, JW Jukema, AH Zwinderman, P de Knijff, R McPherson, ...
New England Journal of Medicine 338 (2), 86-93, 1998
8471998
Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia
JJP Kastelein, SI van Leuven, L Burgess, GW Evans, JA Kuivenhoven, ...
New England Journal of Medicine 356 (16), 1620-1630, 2007
7662007
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
RA Hegele, HN Ginsberg, MJ Chapman, BG Nordestgaard, ...
The lancet Diabetes & endocrinology 2 (8), 655-666, 2014
6002014
Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study
GJ de Grooth, JA Kuivenhoven, AFH Stalenhoef, J de Graaf, ...
Circulation 105 (18), 2159-2165, 2002
5742002
ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice
AJ Murphy, M Akhtari, S Tolani, T Pagler, N Bijl, CL Kuo, M Wang, ...
The Journal of clinical investigation 121 (10), 4138-4149, 2011
5442011
Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study
MC Meuwese, ESG Stroes, SL Hazen, JN van Miert, JA Kuivenhoven, ...
Journal of the American College of Cardiology 50 (2), 159-165, 2007
5272007
The molecular pathology of lecithin: cholesterol acyltransferase (LCAT) deficiency syndromes
JA Kuivenhoven, H Pritchard, J Hill, J Frohlich, G Assmann, J Kastelein
Journal of lipid research 38 (2), 191-205, 1997
4941997
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient …
SM Boekholdt, FM Sacks, JW Jukema, J Shepherd, DJ Freeman, ...
Circulation 111 (3), 278-287, 2005
4072005
Genetic variant of the scavenger receptor BI in humans
M Vergeer, SJA Korporaal, R Franssen, I Meurs, R Out, GK Hovingh, ...
New England Journal of Medicine 364 (2), 136-145, 2011
3742011
A review of CETP and its relation to atherosclerosis
GJ de Grooth, AHEM Klerkx, ESG Stroes, AFH Stalenhoef, JJP Kastelein, ...
Journal of lipid research 45 (11), 1967-1974, 2004
3412004
Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population …
K El Harchaoui, WA van der Steeg, ESG Stroes, JA Kuivenhoven, ...
Journal of the American College of Cardiology 49 (5), 547-553, 2007
3052007
The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?
M Vergeer, AG Holleboom, JJP Kastelein, JA Kuivenhoven
Journal of lipid research 51 (8), 2058-2073, 2010
2972010
Heterogeneity at the CETP Gene Locus: Influence on Plasma CETP Concentrations and HDL Cholesterol Levels
JA Kuivenhoven, P de Knijff, JMA Boer, HA Smalheer, GJ Botma, ...
Arteriosclerosis, thrombosis, and vascular biology 17 (3), 560-568, 1997
2891997
Intramuscular Administration of AAV1-Lipoprotein LipaseS447X Lowers Triglycerides in Lipoprotein Lipase–Deficient Patients
ES Stroes, MC Nierman, JJ Meulenberg, R Franssen, J Twisk, CP Henny, ...
Arteriosclerosis, thrombosis, and vascular biology 28 (12), 2303-2304, 2008
2722008
The system can't perform the operation now. Try again later.
Articles 1–20